Dose Finding Study of MCI-186 in Acute Ischemic Stroke

חו"ל (דורש נסיעה)הסתיים מוקדםPHASE2

מצבים רפואיים

Acute Ischemic Stroke

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Investigational site 13, Aichi, Japan

  • Investigational site 39, Aomori, Japan

  • Investigational site 19, Chiba, Japan

  • Investigational site 28, Chiba, Japan

  • Investigational site 33, Ehime, Japan

  • Investigational site 10, Fukui, Japan

  • Investigational site 05, Fukuoka, Japan

  • Investigational site 09, Fukuoka, Japan

  • Investigational site 11, Fukuoka, Japan

  • Investigational site 12, Fukuoka, Japan

  • Investigational site 18, Fukuoka, Japan

  • Investigational site 21, Fukuoka, Japan

  • Investigational site 32, Fukuoka, Japan

  • Investigational site 37, Fukuoka, Japan

  • Investigational site 07, Fukushima, Japan

  • Investigational site 08, Fukushima, Japan

  • Investigational site 15, Gifu, Japan

  • Investigational site 23, Gifu, Japan

  • Investigational site 02, Gunma, Japan

  • Investigational site 01, Hokkaido, Japan

  • Investigational site 22, Hokkaido, Japan

  • Investigational site 06, Hyōgo, Japan

  • Investigational site 30, Hyōgo, Japan

  • Investigational site 42, Hyōgo, Japan

  • Investigational site 43, Ishikawa, Japan

  • Investigational site 40, Kanagawa, Japan

  • Investigational site 24, Kochi, Japan

  • Investigational site 35, Miyagi, Japan

  • Investigational site 16, Nagano, Japan

  • Investigational site 20, Nagano, Japan

  • Investigational site 27, Numakunai, Japan

  • Investigational site 44, Okayama, Japan

  • Investigational site 41, Okinawa, Japan

  • Investigational site 03, Osaka, Japan

  • Investigational site 25, Osaka, Japan

  • Investigational site 38, Saga, Japan

  • Investigational site 31, Saitama, Japan

  • Investigational site 14, Shimane, Japan

  • Investigational site 29, Tochigi, Japan

  • Investigational site 36, Tochigi, Japan

  • Investigational site 17, Tokyo, Japan

  • Investigational site 45, Tokyo, Japan

  • Investigational site 34, Yamagata, Japan

  • Investigational site 04, Yamaguchi, Japan

  • Investigational site 26, Yamaguchi, Japan

מובילי המחקר
  • General Manager

    Study Director

    Tanabe Pharma Corporation

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)

לא פורסם אימייל או טלפון ליצירת קשר עם צוות הניסוי.